Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data-Reference-Cited by-同舟云学术

Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data

Published:2003-04 Issue:7 Volume:31 Page:525-530
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Tartarone A,Romano G,Galasso R,Iodice G,D'Arena G,Coccaro M,Bochicchio A,Sgambato A,Di Renzo N

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703824.pdf

Reference41 articles.

1. Peters WP, Shpall EJ, Jones RB et al. High dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988; 6: 1368–1376.

2. Kennedy MJ, Beveridge RA, Rowley SD et al. High dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intensive induction as initial therapy for metastatic breast cancer. J Nat Cancer Inst 1991; 83: 920–926.

3. Williams SF, Gilewski T, Mick R et al. High dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report. J Clin Oncol 1992; 10: 1743–1747.

4. Antman KH, Ayash L, Elias A et al. A phase II study of high dose cyclophosphamide, thiotepa and carboplatin with autologous bone marrow support in women with measurable advanced breast cancer responding to standard dose therapy. J Clin Oncol 1992; 10: 102–110.

5. Dunphy FR, Spitzer G, Fornoff JE et al. Factors predicting long-term survival for metastatic breast cancer patients treated with high dose chemotherapy and bone marrow support. Cancer 1994; 74: 125–134.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Status of BoneMarrow Transplantation for Treatment of Cancer;Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures;2010-11-03

2. Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer;Bone Marrow Transplantation;2007-11-26

3. Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplatation in Metastatic Breast Cancer Results in Survival Benefit;The Breast Journal;2006-11

4. Powerful Prognostic Stratification By [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy;Journal of Clinical Oncology;2006-07-01

5. Matrix metalloproteinase–activated doxorubicin prodrugs inhibit HT1080 xenograft growth better than doxorubicin with less toxicity;Molecular Cancer Therapeutics;2005-05